This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARION C. ANDERSON, M.D.; CHARLES J. STALEY, M.D.; EDWARD F. SCANLON, M.D.; FREDERICK W. PRESTON, M.D.

AMA Arch Surg. 1957;75(4):615-624.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

N,N',N''-triethylene thiophosphoramide (Thio-TEPA) belongs to the poly functioning alkylating group of compounds and is closely related pharmacologically to mechlorethamine hydrochloride U. S. P. (nitrogen mustard).¹⁰ It has proved effective in the treatment of certain chronic leukemias and lymphomas.^10,15 In addition, tumors originating in the breast, ovary, and lung have occasionally responded favorably.^1-4,9,14 This report deals with the use of triethylene thiophosphoramide in the attempted palliation of 34 patients with advanced neoplastic disease arising from tissues outside the hematopoietic system.

The mechanism of action of triethylene thiophosphoramide depends on the release of ethylenimine derivatives. These products, when dissolved in tissue fluids, are capable of alkylating a wide variety of organic compounds, including functioning groups of cell proteins. The most likely site of intracellular attack appears to be essential nucleoproteins of cell nuclei.¹⁴

The drug was supplied as a white crystalline powder and was prepared for use in . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Departments of Surgery, Veterans' Administration Research Hospital, Chicago; Evanston Hospital, Evanston, Ill., and Northwestern University Medical School, Chicago.

Footnotes
Submitted for publication March 4, 1957.

Dr. J. M. Ruegsegger, Lederle Laboratories Division, American Cyanamid Company, Pearl River, N. Y., supplied the Thio-TEPA for this study, and Mr. Arnold Kravitz, Veterans' Administration Research Hospital, prepared the drug for injection.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?